top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Brain-Targeted Drug Delivery
Brain-Targeted Drug Delivery
Autore Sousa Flávia
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (260 p.)
Soggetto topico Technology: general issues
Soggetto non controllato drug delivery into the brain
transendothelium based on receptor-mediated transcytosis
immunotherapy
Alzheimer's disease
anti-tau and anti-receptor bispecific monoclonal antibodies
Alzheimer's disease-relevant tau species
temporal-spatial pathological Aβ and tau distribution
interactions between Aβ and tau
tau clearance in microglia
tau clearance in neurons
liposome
nanoparticle
seizure
laser
ultrasound
naringenin
nanostructured lipid carrier
intranasal delivery
central composite rotatable design
depression
pomegranate seed oil
nasal delivery system
memory impairment
movement impairment
delivery to brain
improved memory
phospholipid oily gel
high-grade glioma
diffuse midline glioma
glioblastoma
IL-13Rα2
IL-13
immunotoxin
targeted therapy
GB-13
IL13.E13K-PE4E
receptor expression
acetaminophen
blood-brain barrier
claudin-5
CNS drug delivery
opioids
tight junction
microdialysis
cerebral open flow microperfusion
electrochemical biosensors
macromolecules
tolcapone
microparticles
nanoparticles
PLGA
Parkinson's disease
nose to brain delivery
gene therapy
polyplexes
hyaluronidase
glycol chitosan
brain cancer
chemoattractant
CXCL
CXCR
glioblastoma multiforme
3D cell culture systems
non-human primate
convection-enhanced delivery
neurosurgery
optogenetics
brain targeted therapy
drug delivery
cerebrospinal fluid microcirculation
brain biodistribution
ISBN 3-0365-5281-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910619467203321
Sousa Flávia  
MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Biomarkers and Targets in Digestive Organs
Cancer Biomarkers and Targets in Digestive Organs
Autore Lee Nikki
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (146 p.)
Soggetto non controllato liver graft injury
HFE
neurokinin
chemotherapy
intestinal tumors
therapeutic targets
biliary tract carcinoma
hepatocellular carcinoma
clinical trial
cell adhesion molecules
colorectal cancer
biomarkers
phenotypic mosaics
gastrointestinal oncology
Asian Cancer Research Group (ACRG)
biomarker
psychosocial support
precision therapy
pancreatic carcinoma
precision medicine
Liver transplantation
predictive biomarkers
CD274
cholecystokinin
The Cancer Genome Atlas (TCGA)
gastrin
pembrolizumab
immunotherapy
gastrin-releasing peptide
stereotactic body radiation therapy
immunohistochemistry
gastric carcinoma
liver transplant
CAM invasion assay
intragraft gene expression profiles
molecular profiling
targeted therapy
neurotensin
intestinal disorder
ramucirumab
next-generation sequencing
colorectal carcinoma
tumor progenitor
circulating tumor cells
gastrointestinal malignancies
bombesin
trastuzumab
somatostatin
zebrafish
G protein-coupled receptors
ISBN 3-03921-464-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367564003321
Lee Nikki  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Immunology
Cancer Immunology
Autore Subramanian Subree
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (316 p.)
Soggetto topico Medicine
Soggetto non controllato NKG2D
CAR T
IL-7
prostate cancer
cell therapy
CD19-CAR-T
B cell aplasia
KIR
PD-1
inhibitory CAR
tumor-infiltrating lymphocytes
tumor microenvironment
immunotherapy
NK cells
cancer stem cells (CSCs)
antibody-dependent cellular cytotoxicity (ADCC)
differentiation
cytotoxicity
IFN-γ
osteoclasts
MICA/B mAb
DNA methylation
RNA methylation
S-adenosylmethionine (SAM)
cancer
innate immunity
adaptive immunity
T cells
m6A
PD-L1
resistance
immune checkpoints
cancer vaccine
combination immunotherapy
TCR diversity
organ transplantation
carcinoma
epidemiologic studies
immunosuppression
CTLA-4
Treg cells
immune checkpoint inhibitors
CD28
antigen-presenting cells
IL15
colon cancer
melanoma
uveal
BAP1
anti-PD-1
anti-CTLA-4
TIL
classical and endemic Kaposi Sarcoma
systemic treatment
multi-state modelling
treatment free interval
chemotherapy
interferon
triple negative breast cancer
immunomodulation
bispecific antibody
sortase A
chemo-enzymatic approach
anti-CD20 antibody
Fab
BiFab
colorectal cancer
dendritic cells
Atypical Chemokine Receptor 4 (ACKR4)
T-cell priming
immune checkpoint blockade
primary liver cancer
kynurenine pathway
immune evasion
indoleamine 2,3 dioxygenase 1
tryptophan 2,3 dioxygenase 2
IDO inhibitor
antigen presenting cells
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557349203321
Subramanian Subree  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Metabolism: Molecular Targeting and Implications for Therapy
Cancer Metabolism: Molecular Targeting and Implications for Therapy
Autore Shanmugasundaram Ganapathy-Kanniappan
Pubbl/distr/stampa Frontiers Media SA, 2017
Descrizione fisica 1 electronic resource (114 p.)
Collana Frontiers Research Topics
Soggetto non controllato Tumor microenvironment
metastasis
Cancer Metabolism
glycolysis
immunotherapy
epigenetic regulation
metabolic reprogramming
Warburg effect
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Cancer Metabolism
Record Nr. UNINA-9910688412403321
Shanmugasundaram Ganapathy-Kanniappan  
Frontiers Media SA, 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Nanomedicine
Cancer Nanomedicine
Autore Hoskins Clare
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (510 p.)
Soggetto topico Technology: general issues
Soggetto non controllato antibody drug conjugate (ADC)
PD-L1
tumor spheroid disruption
immune modulation
doxorubicin
graphene oxide
adsorption
cathepsin D
cathepsin L
anti-metastatic enzyme cancer therapy
nanoparticles
targeted delivery system
siRNA
osteopontin
mammary carcinoma
mesenchymal stem cells (MSCs)
TAT peptide
PLGA
paclitaxel
nano-engineered MSCs
orthotopic lung tumor model
intracranial glioma
immunotherapy
CPMV
viral nanoparticles
in situ vaccine
albumin nanoparticles
microbubble
ultrasound
theranostics
hepatocellular carcinoma
VX2 tumor
intra-arterial chemotherapy
lung cancer
nanomedicine
clinical status
cancer therapy
breast cancer
cell signaling
active targeting
passive targeting
EPR effect
oncogenes
nanoparticle
drug delivery
ligand
tumor targeting
biodistribution
Mesoporous silica nanoparticle
drug delivery system
target treatment
lanthanide metal
hyaluronic acid
hyaluronidase
drug combination
everolimus
dual-targeting
magnetic nanoparticles
monoclonal antibodies
nanostructured lipid carrier
platelet membrane
biomimicry
plasmonic photothermal therapy
gold nanorods
surgery
bleeding
dogs
cats
stimuli-responsive
DOX
SN38
CSCs
single-walled carbon nanotubes
chirality separation
NASH
drug-gene delivery
near IR hyperspectral imaging
plasmonics
copper
VEGF
glioblastoma
differentiated neuroblastoma
peptidomimetics
real-time quantitative polymerase chain reaction (qPCR)
actin
combinatorial therapy
anticancer and antibacterial activity
temoporfin
drug-in-cyclodextrin-in-liposome
hybrid nanoparticles
multicellular tumor spheroids
cyclodextrins
photodynamic therapy article
yet reasonably common within the subject discipline
antitumor strategy
biomimetic core–shell nanoparticles
NK cell-derived exosomes
folate receptor
albumin nanoparticle
microfluidic
cabazitaxel
polydopamine nanoparticles
size
cytotoxicity
iron affinity
FA-DABA-SMA
self-assembly
oncogenic proteins
intracellular disruption
folic receptor alpha
pancreatic cancer
parvifloron D
albumin
erlotinib
photodynamic therapy
lipid nanoparticles
tumor vectorization
verteporfin
ovarian carcinomatosis
spheroids
integrin
RGD peptide
cancer diagnosis
radiotherapy
hyperthermia therapy
biomimetic
nanocarrier
membrane-wrapped
cancer
targeted delivery
photothermal therapy
imaging
cancer nanomedicine
tumor microenvironment
nano–bio interactions
clinical translation
magnetic nanowires
magnetic hyperthermia
magnetic actuation
magnetic drug targeting
titanate nanotubes
gold nanoparticles
vectorization
colloidal stability
docetaxel
prostate cancer
mangiferin
anti-topoisomerase activity
extracellular vesicles
exosomes
chemico-physical functionalization
loading
translational medicine
nanotechnology: bioengineering
anacardic acid
mitoxantrone
targeted drug delivery
liposomes
melanoma
apoptosis
ascorbic acid
angiogenesis
epithelial-to-mesenchymal transition
hypoxia
immunosuppression
metabolism
nanotherapeutics
tumour microenvironment
DNA origami
liposome
remote loading
acute toxicity
organoids
magnetic silica-coated iron oxide nanochains
photothermal treatment
hyperthermia
collagen
cellular microenvironment
lymphadenectomy
magnetometer
sentinel lymph node dissection
SPION
superparamagnetic iron oxide nanoparticles
Vδ2 T cells
zoledronic acid
polymeric nanoconstruct
anti-tumor immunity
colorectal carcinoma
β-cyclodextrin nanosponges
BALB-neuT mice
brain tumours
glioma
blood brain barrier
polymeric nanoparticles
PEGylation
dioleoylphosphatidylethanolamine
poly(hydroxyethyl acrylate-co-allyl methyl sulfide) copolymer
folate
oxidation-sensitive release
cellular interaction
in vitro anti-cancer activity
triple negative breast cancer
organotin
mesoporous silica nanoparticles
MDA-MB-231
theranostic nanomaterials
nanobiotechnology
molecular imaging
nanosystems
nanomicelles
ovarian cancer
tumour targeting
chemotherapeutics
riboflavin
vitamin B2
nanomedicines
secondary structure
mixed micelle
pH responsive
targeted therapy
anti-cancer
shear stress
flow
in vitro
therapeutics
diagnostics
Immunotherapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557114703321
Hoskins Clare  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Critical Issues in Head and Neck Oncology : Key Concepts from the Seventh THNO Meeting / / edited by Jan B. Vermorken, Volker Budach, C. René Leemans, Jean-Pascal Machiels, Piero Nicolai, Brian O’Sullivan
Critical Issues in Head and Neck Oncology : Key Concepts from the Seventh THNO Meeting / / edited by Jan B. Vermorken, Volker Budach, C. René Leemans, Jean-Pascal Machiels, Piero Nicolai, Brian O’Sullivan
Autore Vermorken Jan B
Edizione [1st ed. 2021.]
Pubbl/distr/stampa Springer Nature, 2021
Descrizione fisica 1 online resource (IX, 373 p. 39 illus., 33 illus. in color.)
Disciplina 616.994
Soggetto topico Oncology  
Radiotherapy
Surgical oncology
Oncology
Surgical Oncology
Càncer de coll
Càncer de cap
Cirurgia oncològica
Soggetto genere / forma Llibres electrònics
Soggetto non controllato Oncology
Radiotherapy
Surgical Oncology
Internal Medicine
Radiology
Surgery
Nasopharynx cancer
Head and Neck Squamous Cell Cancer
non-oropharyngeal head and neck cancer
predictive biomarkers
liquid biopsies
induction chemotherapy
immunotherapy
precision medicine
HNSCC
Open Access
ISBN 3-030-63234-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Biomarkers in Head and Neck Squamous Cell Cancer (HNSCC) -- Promising biomarkers for early diagnosis and prognosis prediction in HNS -- Biomarkers to predict radiotherapy toxicity -- Biomarkers for hypoxia, HPVness and proliferation from imaging perspective -- Mechanism of cetuximab resistance and how to overcome it -- The role of liquid biopsy for monitoring disease evolution -- NK cells in immunotherapy: how important are they? -- Biomarkers for immune modulatory treatment in HNSCC -- Primary disease (1) -- Novel approaches in surgical management of HNSCC -- The surgical approach to elderly patients with HNSCC -- The nonsurgical approach to locoregionally advanced HNSCC -- High-dose three-weekly or low-dose weekly cisplatin during radiation, what to prefer? -- Primary disease (2) -- Where and when to use induction chemotherapy? -- Prognostic role of p16/HPV in non-oropharyngeal head and neck cancer -- Is there a role for neoadjuvant targeted and immunotherapies? -- Is there a role for adjuvant targeted and immunotherapies? -- Optimal supportive measures during primary treatment -- Precision Medicine in head and neck cancer: myth or reality -- Recurrent and / or metastatic disease -- Salvage surgery: candidates, safe reconstruction, and results? -- Re-irradiation for local relapses or second primaries: when and how? -- New promising targeted agents in first and second-line settings -- Update of immune therapies in recurrent/metastatic HNSCC -- Special Issue -- Patients with rare head neck cancers: do they need a different approach? .-Nasopharynx cancer -- New epidemiological aspects -- New developments in the management of nasopharyngeal carcinoma -- New drugs for recurrent/metastatic nasopharynx cancer.
Record Nr. UNINA-9910484360603321
Vermorken Jan B  
Springer Nature, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Current Perspectives, Challenges and Advances in Cell Based Therapies
Current Perspectives, Challenges and Advances in Cell Based Therapies
Autore Trikha Prashant
Pubbl/distr/stampa Frontiers Media SA, 2020
Descrizione fisica 1 electronic resource (192 p.)
Soggetto topico Medicine
Oncology
Soggetto non controllato immunotherapy
NK cell
tumor micoenvironment
CAR (chimeric antigen receptor) T cells
cell based therapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557622203321
Trikha Prashant  
Frontiers Media SA, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Delivery of Molecules Using Nanoscale Systems for Cancer Treatment and/or Diagnosis
Delivery of Molecules Using Nanoscale Systems for Cancer Treatment and/or Diagnosis
Autore Franco Marina Santiago
Pubbl/distr/stampa Basel, : MDPI Books, 2022
Descrizione fisica 1 electronic resource (302 p.)
Soggetto topico Medicine
Pharmacology
Soggetto non controllato nanostructured lipid carriers
doxorubicin
mucositis
cell internalization
albumin
BSA
CPP
gold nanorods
gold nanoprisms
arginine-rich peptide
glutathione
nanoparticles
oxidative stress
breast cancer
gastric cancer
nanoparticle
fucoidan
d-alpha-tocopherylpoly (ethylene glycol) succinate
combination chemotherapy
G-quadruplex
nucleolin
DNA nanocages
intracellular localization
cancer targeting
molecular dynamics simulations
mesoporous silica nanoparticles
radiotherapy
immunotherapy
tumor microenvironment
abscopal effect
magnetofection in vivo
magnetic nanoparticles
iron oxide
gene delivery
gene vectors
codelivery nanocarriers
photodynamic therapy
anticancer therapies
combination therapy
phthalocyanine
uterine cervical neoplasms
photochemotherapy
in vitro
in vivo
nanocarrier
polyplexes
siRNA delivery
glioblastoma therapy
amphiphilic poly(α)glutamate
P-selectin
prodrug
drug delivery
targeted therapy
chemotherapy
prostate cancer
prostate-specific membrane antigen
targeted delivery
encapsulation
cabazitaxel
nanocarriers
nanosystems
radiosensitizer
hypoxia
synergism
cancer
photothermal therapy
combined antitumor effect
oxygenation
hydrogel
hypoxic tumor
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910595074103321
Franco Marina Santiago  
Basel, : MDPI Books, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Diabetology: Feature Papers 2021
Diabetology: Feature Papers 2021
Autore Clifton Peter
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (158 p.)
Soggetto topico Medicine
Soggetto non controllato carpal tunnel syndrome
ultrasound
power doppler signal
diabetes
FINDRISC
prediabetes
metabolic syndrome
young-adults
N-acetyl-β-d-glucosaminidase (NAG)
diabetic nephropathy
chronic kidney disease (CKD)
meta-analysis
systematic review
focus groups
self-management of type 2 diabetes
patients' experiences
healthcare professionals
middle-aged population
type 1 diabetes
autoimmune diseases
pancreatic β-cells
tolerance
regulatory T cells
immunotherapy
insulin
banting
best
MacLeod
collip
limited-resource countries (LRC)
insulin pumps
blood glucose monitoring
continuous blood glucose sensors
COVID-19
SARS-CoV-2
ACE2
TMPRSS2
mucormycosis
COVID-associated mucormycosis (CAM)
mucins
Diabetic Keto Acidosis (DKA)
Metabolic-Stress-Associated Interactome (MSAI)
olfactory neurovascular niche
serine proteases
ferroptosis
redox-iron stress
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Diabetology
Record Nr. UNINA-9910576881103321
Clifton Peter  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
Autore Ecke Thorsten
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (240 p.)
Soggetto topico Medicine
Soggetto non controllato Metallothionein
urothelium
urothelial cancer
cadmium exposure
zinc transporter
bladder
TAGLN
F-actin
PTEN
p53
tumorigenesis
proliferation
invasion
TERT promoter mutations
FGFR3
non muscle invasive bladder cancer
BCG therapy
bladder cancer
JAK-STAT pathway
combination therapy
oncolytic adenovirus
virotherapy
STAT3/5 inhibitor
JAK inhibitor
XVir-N-31
bladder cancer detection
urinary biomarkers
DNA methylation
ECRG4
ITIH5
biomarker
cancer
grade
metabolomics
MS
NMR
biomarkers
tumor markers
prognosis
heparanase
syndecan-1
heparan sulfate proteoglycans (HSPGs)
urothelial carcinoma
miRNA
quantitative PCR
tumor marker
voided urine cytology
KDM7A
histone demethylase
TC-E 5002
androgen receptor
drug resistance
non-invasive detection
telomerase
somatic mutations
TERT promoter region
muscle-invasive bladder cancer
chemotherapy
immunotherapy
personalized medicine
predictive biomarker
survivin
BIRC5
macrophage
KRT20
ERBB2
MIBC
prediction
RT-qPCR
adjuvant chemotherapy
survival
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557142003321
Ecke Thorsten  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui